Key facts
- It has raised $15.4M; the latest was Later Stage VC in Dec 2025.
- Notable investors include Puhua Capital, SND Ventures Group, Sinovation Ventures, Ascendin Fund, DYEE Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Belle Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for Belle Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Belle Healthcare
Manufacturer of medical instruments intended to develop the precision and standardization of microsurgery in China. The company's instruments include disposable instruments, ear nose and throat (ENT) instruments and consumable products to be primarily used in minimally invasive ophthalmology and tympanoplasty surgeries, enabling surgeons to engage in more precise eye and ear microsurgery.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2009
- Employees
- 48
- Website
- bellehealth.cn/
- Ownership
- Privately Held (backing)
Belle Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Belle Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Belle Healthcare in its N-PORT filings yet. We sweep new filings monthly.